Quiz 2  

'This supplemental new drug application provides for the use TAXOTERE in combination with cisplatin for the treatment of ... . . What should we select as generic or innovator type for this case?

What should we select as generic or innovator type for Photrex according to info given?

What should we select as generic or innovator type for APD515 and APD515 Topical, respectively?

Assume that there is a news telling us that Photrex is approved. What should we select as generic or innovator type for Photrex?

Assume that there is a news telling us that Photrex is approved. What should we select as generic or innovator type for MV2101?

What should we select as generic or innovator type for above product? (Hint. CYC202 is a non-approved product)

How many of the rows given are incorrect?

Molecule X was only approved in Japan previously and the company is developing a new product, ABC-103, using that molecule in the USA. What should we select as type for ABC-103 in this case?

'Compound X is an intraocular, polymer implant containing human retinal epithelial cells genetically modified to continually deliver... ' What should we select as type for Compound X?

Compound X is a subcutaneous formulation which is on market. You have a news telling that intramuscular formulation of the product is approved later on. In this case, ... ...